News Releases :: Sutro Biopharma, Inc. (STRO)

Jul 17, 2017 8:00 am EDT

New Evidence of Sutro ADC's Potency in Human Tumor Xenografts

Apr 27, 2017 8:00 am EDT

Sutro Appoints Lobacki as Director; Leonard, Krishnan & Levy as Advisors

Apr 3, 2017 8:00 am EDT

Sutro ADC Targeting CD74 Eradicates B-Cell Hematologic Malignancy, Prolongs Survival in Tumor Models

Dec 6, 2016 8:00 am EST

Sutro ADC Targeting CD74 Exhibits Potent Anti-tumor Activity in Multiple Malignant Cell Lines and Animal Models of Non-Hodgkin Lymphoma and Multiple Myeloma

Sep 19, 2016 8:00 am EDT

Sutro ADCs Targeting CD74 Suppress Tumors in Multiple Malignant Cell Lines and Animal Models of Multiple Myeloma and Non-Hodgkin Lymphoma

Sep 7, 2016 8:00 am EDT

Sutro Marks Important Progress -- Receives Two Milestone Payments from Celgene

Jun 1, 2016 8:00 am EDT

Sutro Appoints Shabbir T. Anik Chief Technical Operations Officer

Mar 9, 2016 10:00 am EST

Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development

Nov 18, 2015 9:00 am EST

Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association

Aug 4, 2015 9:00 am EDT

Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management